Patents by Inventor Alexander Brandis

Alexander Brandis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7045117
    Abstract: Palladium-substituted Bacteriochlorophyll derivatives are administered to a subject suspected of having a tumor and the patient is then irradiated and the fluorescence of the suspected area is measured. A high fluorescence indicates a tumor site. A preferred derivative is Pd-Bacteriopheophorbide a.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: May 16, 2006
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Avigdor Scherz, Yoram Salomon, Alexander Brandis, Hugo Scheer
  • Publication number: 20030211044
    Abstract: Palladium-substituted Bacteriochlorophyll derivatives are administered to a subject suspected of having a tumor and the patient is then irradiated and the fluorescence of the suspected area is measured. A high fluorescence indicates a tumor site. A preferred derivative is Pd-Bacteriopheophorbide a.
    Type: Application
    Filed: April 16, 2003
    Publication date: November 13, 2003
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Avigdor Scherz, Yoram Salomon, Alexander Brandis, Hugo Scheer
  • Publication number: 20030148926
    Abstract: Novel C-132-COXR1, C-172-COXR2 and C-132-COXR1, C-172-COXR1 derivatives of chlorophyll and bacteriochlorophyll compounds are provided wherein X is O, S or N and R1 and R2, the same or different, may be an optionally substituted hydrocarbyl, amino acid, peptide, protein or saccharide radical. The compounds are for use in photodynamic therapy (PDT), for diagnosis of tumors, and for killing cells and infectious agents such as bacteria and virus, both in biological products and in living tissues.
    Type: Application
    Filed: November 6, 2002
    Publication date: August 7, 2003
    Inventors: Hugo Scheer, Nina Kammhuber, Avigdor Scherz, Alexander Brandis, Yoram Salomon
  • Patent number: 6569846
    Abstract: Palladium-substituted Bacteriochlorophyll derivatives of formula (I), wherein A represents OH, OR1, —O—(CH2)n—Y, —S—(CH2)n—Y, —NH—(CH2)n—Y, —O—(CH2)2—NH2, —O—(CH2)2—OH, —NH—(CH2)n—+N o, X—, —NH0(CH2)2—NH═BOC or —N—(CH2—CH═CH2)2; wherein R1 represents Na+, K+, (Ca2+)0, 5, (Mg2+)0, 5, Li+, NH4+, NH3—C(CH2OH)3 +NH3—CH2—(CHOH)4—CH2OH, +NH2(CH3)—CH2—(CHOH)4—CH2OH or +N(CN′H2n′+1)4; R2 represents H, OH or COOR4, wherein R4 is C1-C12 alkyl or C3-C12 cycloalkl; R3 represents H, OH or C1-C12 alkyl or alkoxy; n is 1, 2, 3, 4, 5 or 6, Y is —NR′1R′2R′3, X-wherein R′1, R′2 and R′3 independently from each other represent —CH3 or —C2H5; X is F, Cl, Br or 1, n′ is 1, 2, 3 or 4 and their oxidized forms, are u
    Type: Grant
    Filed: September 18, 2001
    Date of Patent: May 27, 2003
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Avigdor Scherz, Yoram Salomon, Alexander Brandis, Hugo Scheer
  • Patent number: 6333319
    Abstract: The present invention relates to a new method of preparation of metalated bacteriochlorophyll derivatives for use in methods of in vivo photodynamic therapy (PDT) and diagnosis and in vitro photodynamic killing of viruses and microorganisms, and to some novel metal-substituted bacteriochlorophyll derivatives.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: December 25, 2001
    Assignee: Yeda Research and Development Co., Ltd.
    Inventors: Avigdor Scherz, Yoram Salomon, Hugo Scheer, Gerhard Hartwich, Alexander Brandis
  • Patent number: 6147195
    Abstract: Conjugates of chlorophyll (Chl) and bacteriochlorophyll (Bchl) derivatives with amino acids, peptides and proteins are provided by the invention. The amino acid, peptide or protein residue is linked to the 17-propionic acid group of a Chl or Bchl residue directly or through a chain. The conjugates are for use as photosensitizers in photodynamic therapy and in diagnostics of tumors. Conjugation with cell-specific ligands, such as hormones, growth factors or tumor-specific antibodies, will target the Chl or Bchl moiety to the tumor site. Thus, conjugates with melanocyte stimulating hormones are suitable for photodynamic therapy of melanoma tumors.
    Type: Grant
    Filed: March 3, 1998
    Date of Patent: November 14, 2000
    Assignee: Yeda Research and Development Co., Ltd.
    Inventors: Avigdor Scherz, Yoram Salomon, Leszek Fiedor, Alexander Brandis